LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

DaVita Inc

Closed

Sector Healthcare

150.04 1.06

Overview

Share price change

24h

Current

Min

149.71

Max

151.06

Key metrics

By Trading Economics

Income

-17M

223M

Sales

120M

3.2B

P/E

Sector Avg

15.71

103.001

EPS

2.59

Profit margin

6.98

Employees

70,000

EBITDA

-13M

645M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+2.53 upside

Dividends

By Dow Jones

Next Earnings

5 lis 2024

Market Stats

By TradingEconomics

Market Cap

13B

Previous open

148.98

Previous close

150.04

News Sentiment

By Acuity

12%

88%

13 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

DaVita Inc Chart

Related News

15 lip 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

13 mar 2024, 13:00 UTC

Top News

Healthcare Investors Aren't Scared of Trump or Biden -- WSJ

11 paź 2023, 09:05 UTC

Hot Stocks

Stocks to Watch Wednesday: LVMH, Birkenstock, Novo Nordisk -- WSJ

Peer Comparison

Price change

DaVita Inc Forecast

Price Target

By TipRanks

2.53% upside

12 Months Forecast

Average 152.5 USD  2.53%

High 165 USD

Low 145 USD

Based on 5 Wall Street analysts offering 12 month price targets forDaVita Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

5 ratings

0

Buy

4

Hold

1

Sell

Technical Score

By Trading Central

148.77 / 154.75Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

13 / 365 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About DaVita Inc

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.